LEUCADIA

Leucadia Therapeutics

This company develops an implantable medical device to restore cerebrospinal fluid flow for patients with Alzheimer's disease and mild cognitive impairment.

Neuromedical

This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.

Cogniguard

This company develops non-invasive vagus nerve stimulation medical devices to treat patients with Alzheimer's disease and mild cognitive impairment.

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.

AgentT

This diagnostics company develops blood tests for early Alzheimer's disease detection to support pharmaceutical drug development and clinical screening.

Sinaptica Therapeutics

The company develops non-invasive neuromodulation systems for Alzheimer's patients to slow cognitive decline using personalized brain stimulation technology.

Neuraworx

This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.

CereVasc

This medical device company develops a minimally invasive endovascular shunt system to treat patients suffering from communicating hydrocephalus and other neurological brain disorders.